You are here

STTR Phase I: Rapid Acting Disinfectant Spray for Slowing the Spread of COVID-19

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 2032056
Agency Tracking Number: 2032056
Amount: $255,536.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: CT
Solicitation Number: N/A
Solicitation Year: 2020
Award Year: 2020
Award Start Date (Proposal Award Date): 2020-08-01
Award End Date (Contract End Date): 2021-07-31
Small Business Information
United States
DUNS: 116952204
HUBZone Owned: No
Woman Owned: Yes
Socially and Economically Disadvantaged: Yes
Principal Investigator
 Christina Drake
 (407) 413-4180
Business Contact
 Christina Drake
Phone: (407) 413-4180
Research Institution
 The University of Central Florida Board of Trustees
 Griffith Parks
Orlando, FL 32816
United States

 Nonprofit College or University

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project is development of a disinfectant spray to curb the transmission of SARS-CoV-2 via contact with contaminated surfaces. COVID-19 transmission occurs primarily via respiratory droplets produced by an infected person and by contact with a surface where a droplet containing the virus exists. Mitigating infection by contact with surfaces is a measure that will slow the spread of novel viruses ahead of development of a vaccine or other protective measures. In conjunction with other measures, a novel disinfectant will support public health during the COVID-19 pandemic. Current disinfectants require times ranging from 30 seconds to 10 minutes for disinfection to begin after application and do not continue to disinfect. The proposed technology creates a temporary, continually disinfecting film that remains on the application surface. This STTR Phase I project will demonstrate both the rapid performance of a novel spray and its ability to form a temporary and continually disinfecting film post=application. This technology employs a select medium containing fast-response doped nanoceria where the oxidizing response/mechanism is engineered to perform several disinfectant reactions in parallel. A safe, rapid, multi-disinfectant approach using engineered nanoceria has not previously been demonstrated for use. The project will also demonstrate the post-application disinfection properties. The goals of this project will be achieved with the following: 1) development of an anti-viral, multi-mechanism disinfectant formulation, 2) demonstration of efficacy and safety, 3) study of product stability, and 4) demonstration of temporary film formation, stability, and activity. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government